<DOC>
	<DOCNO>NCT00302497</DOCNO>
	<brief_summary>The long-term use calcineurin inhibitor maintenance phase kidney transplantation associate typical adverse effect , potential contribution progressive impairment renal function , hypertension , metabolic abnormality . This 15 month study safety follow undertaken evaluate potential benefit alternative treatment strategy chronic use CNI . It establish , comparative design , superior protection kidney function provide chronic usage basiliximab tacrolimus early post-transplantation use EDC kidney .</brief_summary>
	<brief_title>EXTEND Protocol Transplanted Patient Evaluate Kidney Function</brief_title>
	<detailed_description />
	<mesh_term>Basiliximab</mesh_term>
	<criteria>male female patient age 40 75 year viable graft patient recipient primary secondary graft cadaveric expand donor criterion patient change immunosuppressor two week prior baseline patient acute rejection four week prior baseline patient willing capable give write informed consent study participation female childbearing potential must negative serum pregnancy test within 7 day prior baseline.Effective contraception must use trial 6 week follow discontinuation study medication , even history infertility Patients HCV HBV negative Exclusion Criteria patient calculate GFR ( Nankivell formula ) less 30mL/min baseline Patients recipients multiple organ transplant Patients recipient dual kidney transplant Patients panel reactive antibody &gt; 50 % transplant Patients know hypersensitivity tacrolimus , ECMPS basiliximab baseline Patients know malignancy history malignancy , successfully treat nonmetastatic basal squamous cell carcinoma skin Patients HIV positive study entry Patients receive kidney HCV positive HBV positive donor Patients sign active immune process graft biopsy baseline Patients polyoma ( BK JC ) Patients operative technical failure</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2006</verification_date>
</DOC>